SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rosen PP, Frachia AA, Urban JA, et al. Residual mammary carcinoma following simulated partial mastectomy. Cancer. 1975; 35: 739744.
  • 2
    Holland R, Veling SHJ, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer. 1985; 56: 979990.
  • 3
    Faverly DRG, Hendriks JHCL, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001; 91: 647659.
  • 4
    Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): relationship of local recurrence to multicentricity. Cancer. 1986; 57: 17171724.
  • 5
    Veronesi U, Liuini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993; 328: 15871591.
  • 6
    Liljegren G, Holmberg L, Adami HO, et al., for the Uppsala-Oreboro Breast Cancer Study Group. Sector resection with or without post-operative radiotherapy for Stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst. 1994; 86: 717722.
  • 7
    Clark RM, Whelan T, Levine M, et al., for the Ontario Clinical Oncology Group. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. An update. J Natl Cancer Inst. 1996; 88: 16591664.
  • 8
    Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathologic findings from NSABP protocol B-06. Semin Surg Oncol. 1992; 8: 161166.
  • 9
    Gage I, Recht A, Gelman R, et al. Long-term outcome following breast conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995; 33: 245251.
  • 10
    Wazer DE, Schmidt-Ullrich RK, Schmid C, et al. Factors determining outcome for breast-conserving irradiation with margin directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998; 40: 851858.
  • 11
    Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992; 326: 10971101.
  • 12
    Dolan JT, Granchi TS, Miller CC III, et al. Low use of breast conservation surgery in medically indigent populations. Am J Surg. 1999; 178: 470474.
  • 13
    Hevert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendation for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999; 85: 11041113.
  • 14
    Du X, Freeman JL, Freeman DH, et al. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1985. J Gerontol A Biol Sci Med Sci. 1999; 54: 474478.
  • 15
    Athas WF, Adams-Cameron M, Hunt WC, et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92: 269271.
  • 16
    Arthur D, Vicini F, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2002; 1: 184190.
  • 17
    Wazer DE, Berle L, Graham R, et al. Preliminary results of a Phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 889897.
  • 18
    Vicini FA, Chen PY, Fraile M, et al. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial. Int J Radiat Oncol Biol Phys. 1997; 38: 301310.
  • 19
    Kuske R, Bolton JS, McKinnon WMP, et al. Five-year results of a prospective Phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer [abstract]. Int J Radiat Oncol Biol Phys. 1998: 42 (Suppl 1): 181.
  • 20
    Kuske R, Bolton JS. A Phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma. Radiation Therapy Oncology Group Pub. No. 1055. Philadelphia: Radiation Therapy Oncology Group, 1995.
  • 21
    Clarke DH, Vicini FA, Jacobs H, et al. High dose rate brachytherapy for breast cancer. In: NagS, editor. High dose rate brachytherapy: a textbook. Arnonk, NY: Futura Publishing, 1994: 321329.
  • 22
    Fentimen IS, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 1991; 27: 447450.
  • 23
    Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol. 1997; 65: 263267.
  • 24
    Martinez AA, Chen PY, Gustafson G, et al. Irradiation of the tumor bed alone after lumpectomy with high dose rate brachytherapy. In: Proceedings of the 19th Annual Meeting of the American Brachytherapy Society, 1997.
  • 25
    King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg. 2000; 180: 299304.
  • 26
    Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001; 19: 19932001.
  • 27
    Vicini FA, Jaffray DA, Horwitz EM, et al. Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 1998; 40: 629635.
  • 28
    Vicini FA, Kini VR, Chen P, et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol. 1999; 70: 3340.
  • 29
    Vicini FA, Kestin LL, Edmundson GK, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 803810.
  • 30
    Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001; 50: 10031011.
  • 31
    Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer Int J Radiat Oncol Biol Phys. 2001; 50: 107111.
  • 32
    Zwicker RD, Schmidt-Ullrich RK. Dose uniformity in a planar interstitial implant system. Int J Radiat Oncol Biol Phys. 1995; 31: 149155.
  • 33
    Wazer DE, DiPetrillo TA, Schmidt-Ullrich RK, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol. 1992; 10: 356363.
  • 34
    Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002; 52: 11321139.
  • 35
    Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003; 55: 289293.
  • 36
    Wazer DE, Kramer B, Schmid C, et al. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys. 1997; 39: 381393.
  • 37
    Kramer B, Arthur DW, Ulin K, et al. Cosmetic outcome in patients receiving an interstitial implant as part of breast conservation therapy. Radiology. 1999; 213: 6166.